Sonya Ferguson

Sonya Ferguson

Director/Board Member at FUSION ANTIBODIES PLC

Net worth: 4 142 $ as of 2024-04-29

53 year
Health Technology
Health Services
Consumer Services

Profile

Sonya Maria Ferguson is currently a Senior Independent Non-Executive Director at Fusion Antibodies Plc, a Senior Director at Q2 Solutions, and the Global Head-External Relationship Management at Novartis Pharmaceuticals UK Ltd.
Previously, she worked as a Director-Client Operations at Quintiles UK Ltd.
from 2013 to 2016, a Director at Belfast Charitable Society from 2014 to 2018, a Director at Randox Laboratories (India) Pvt Ltd., and a Senior Manager at Randox Laboratories Ltd.
She received her undergraduate and doctorate degrees from Queen's University of Belfast in 1999.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-03-30 102,567 ( 0.11% ) 4 142 $ 2024-04-29

Sonya Ferguson active positions

CompaniesPositionStart
FUSION ANTIBODIES PLC Director/Board Member 2015-12-31
Director/Board Member 2016-03-31
Corporate Officer/Principal -
All active positions of Sonya Ferguson

Former positions of Sonya Ferguson

CompaniesPositionEnd
Director/Board Member 2018-07-31
Quintiles UK Ltd. Corporate Officer/Principal 2016-02-29
Corporate Officer/Principal -
Director/Board Member -
See the detail of Sonya Ferguson's experience

Training of Sonya Ferguson

Queen's University of Belfast Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sonya Ferguson's experience

Connections

62

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
FUSION ANTIBODIES PLC

Health Services

Private companies6

Health Technology

Quintiles UK Ltd.

Health Technology

Health Services

Miscellaneous

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Sonya Ferguson
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW